静脉疾病生活质量评估的最新综述
本综述基于OVID Embase和Medline检索(1993年1月1日至2022年6月30日)的112项研究,评估8种慢性静脉疾病特异性患者报告结局测量工具(PROM)的验证证据,仅慢性静脉功能不全问卷和Charing Cross静脉溃疡问卷分别在无溃疡和有溃疡患者中达到全部三阶段验证标准。
要点
- 8种疾病特异性PROM中仅2种在预设三阶段验证中达标。
- 慢性静脉功能不全问卷适用于C1–C4期患者。
- Charing Cross静脉溃疡问卷适用于C5–C6期患者。
核心结论
- 8种PROM中仅2种在每一阶段均达到预设验证标准,慢性静脉功能不全问卷和Charing Cross静脉溃疡问卷应分别考虑用于无静脉溃疡和有静脉溃疡的慢性静脉疾病患者。
研究设计与样本
- 在OVID Embase和Medline检索1993年1月1日至2022年6月30日的英文文献,四位研究者筛选摘要和标题后对全文进行资格筛选。
- 共筛选2338项唯一研究,112项(4.8%)符合纳入标准,提取疾病特异性PROM的验证数据。
- 采用经典测试理论框架评估内容效度、可靠性(结构效度、内部信度、重测信度)、反应性及验证证据库扩展。
- PROM按所开发人群的疾病表现分为三组:整体慢性静脉疾病(C1–C6)、C1–C4疾病、C5–C6疾病。
- 验证分三阶段评估:内容效度(阶段1);结构效度、信度和反应性(阶段2);验证证据库扩展(阶段3)。
主要发现
- 共识别8种疾病特异性PROM,按上述三组分类。
- 慢性静脉功能不全问卷在C1–C4疾病患者中达到全部三阶段验证标准。
- Charing Cross静脉溃疡问卷在C5–C6疾病患者中达到全部三阶段验证标准。
- 无PROM在整体慢性静脉疾病(C1–C6)中达到全部验证标准。
关键数值与推荐
- 验证标准包括内容效度、结构效度、内部信度、重测信度、反应性及验证证据库扩展(随机对照试验和比较效果研究中的使用、文化或语言翻译、预测效度、建立最小临床重要差异阈值)。
- 最小临床重要差异阈值定义为患者感知为有意义变化的最小结局或测量变化量。
临床怎么用
- 作者认为,慢性静脉功能不全问卷应考虑用于无静脉溃疡的慢性静脉疾病患者。
- 作者认为,Charing Cross静脉溃疡问卷应考虑用于有静脉溃疡的慢性静脉疾病患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Chronic venous disease is a common condition and has a significant impact on patients' health status. Validated patient-reported outcome measures (PROMs) used to assess health status are needed to measure health status. This state-of-the-art review summarizes the current validation evidence for disease-specific PROMs for chronic venous disease and provides a framework for their use in the clinical setting. METHODS: A literature search in OVID Embase and Medline was conducted to identify relevant English-language studies of chronic venous disease that used disease-specific PROMs between January 1, 1993, and June 30, 2022. Abstracts and titles from identified studies were screened by four investigators, and full-text articles were subsequently screened for eligibility. Data on validation of disease-specific PROMs was abstracted from each included article. Classical test theory was used as a framework to examine a priori defined validation criteria for content validity, reliability (construct validity, internal reliability, and test-retest reliability), responsiveness, and expansion of the validation evidence base (use in randomized controlled trials and comparative effectiveness research, cultural or linguistic translations, predictive validity, or establishing the minimal clinically important difference threshold, defined as smallest amount an outcome or measure is perceived as a meaningful change to patients). The PROMs were categorized into three groups based on the manifestations of disease of the population for which they were developed. The overall validity of each PROM was assessed across three stages of validation including content validity (phase 1); construct validity, reliability, and responsiveness (phase 2); and expansion of the validation evidence base (phase 3). RESULTS: Of 2338 unique studies screened, 112 studies (4.8%) met inclusion criteria. The eight disease-specific PROMs identified were categorized into three groups: (1) overall chronic venous disease (C1 to C6); (2) C1 to C4 disease; and (3) C5 to C6 disease. Assessed by group, the Chronic Venous Insufficiency Questionnaire met criteria for validation at all three phases for patients with C1 to C4 disease, and the Charing Cross Venous Ulcer Questionnaire met criteria for validation at all three phases for patients with C5 to C6 disease. There were no PROMs that met all criteria for validation for use in overall chronic venous disease (C1 to C6). CONCLUSIONS: Of the eight PROMs assessed in this review, only two met prespecified criteria at each phase for validation. The Chronic Venous Insufficiency Questionnaire and Charing Cross Venous Ulcer Questionnaire should be considered for use in patients with chronic venous disease without venous ulcers and with venous ulcers, respectively.
引用
- Cleman J, Xia K, Haider M, et al. A state-of-the-art review of quality-of-life assessment in venous disease. J Vasc Surg Venous Lymphat Disord. 2023. PMID: 38128828. doi:10.1016/j.jvsv.2023.101725
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。